Jamie A. Donadio
2016
In 2016, Jamie A. Donadio earned a total compensation of $1.3M as Senior Vice President and Chief Financial Officer at Mirati Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $72,000 |
|---|---|
| Option Awards | $885,008 |
| Salary | $293,665 |
| Other | $2,500 |
| Total | $1,253,173 |
Donadio received $885K in option awards, accounting for 71% of the total pay in 2016.
Donadio also received $72K in non-equity incentive plan, $293.7K in salary and $2.5K in other compensation.
Rankings
In 2016, Jamie A. Donadio's compensation ranked 7,169th out of 14,075 executives tracked by ExecPay. In other words, Donadio earned more than 49.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,169 out of 14,075 | 49th |
Division Manufacturing | 2,699 out of 5,489 | 51st |
Major group Chemicals And Allied Products | 884 out of 1,895 | 53rd |
Industry group Drugs | 684 out of 1,538 | 56th |
Industry Pharmaceutical Preparations | 544 out of 1,176 | 54th |
Source: SEC filing on April 19, 2019.
Donadio's colleagues
We found five more compensation records of executives who worked with Jamie A. Donadio at Mirati Therapeutics in 2016.
2016
Charles Baum
Mirati Therapeutics
Chief Executive Officer
2016
Mark Gergen
Mirati Therapeutics
Former Executive Vice President and Chief Operations Officer
2016
James Christensen
Mirati Therapeutics
Chief Scientific Officer
2016
Isan Chen
Mirati Therapeutics
Executive Vice President and Chief Medical and Development Officer
2016
Chris LeMasters
Mirati Therapeutics